A. Magadum and F. B. Engel, PPARbeta/delta: Linking Metabolism to Regeneration, Int. J. Mol. Sci, vol.90720, p.13, 2018.

P. Luz-crawford, PPARbeta/delta directs the therapeutic potential of mesenchymal stem cells in arthritis, Ann. Rheum. Dis, 2016.

D. K. Kramer, Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle, J. Biol. Chem, vol.282, 2007.

S. M. Reilly and C. H. Lee, PPAR delta as a therapeutic target in metabolic disease, FEBS Lett, vol.582, p.40, 2007.

K. S. Kilgore and A. N. Billin, PPARbeta/delta ligands as modulators of the inflammatory response, Curr. Opin. Investig. Drugs, vol.9, pp.463-469, 2008.

G. D. Barish, PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis, Proc. Natl. Acad. Sci. USA 105, pp.4271-4276, 2008.

M. Krampera, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, vol.101, pp.3722-3729, 2003.

C. H. Lee, Peroxisome proliferator-activated receptor delta promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophage, Proc. Natl. Acad. Sci. USA 103, pp.2434-2439, 2006.

S. Galvan-pena and L. A. O'neill, Metabolic reprograming in macrophage polarization, Front. Immunol, vol.5, 2014.

K. Kang, Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity, Cell Metab, vol.7, pp.485-495, 2008.

, Scientific RepoRtS |, vol.10, p.11423, 2020.

Z. Hu, Q. Zou, and B. Su, Regulation of T cell immunity by cellular metabolism, Front. Med, vol.12, pp.463-472, 2018.

P. Luz-crawford, Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway, PLoS ONE, vol.7, p.72, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00758222

P. Luz-crawford, Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer, Stem Cell Res. Ther, vol.10, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02376241

A. C. Court, Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response, EMBO Rep, vol.21, 2020.

H. M. Wobma, Dual IFN-gamma/hypoxia priming enhances immunosuppression of mesenchymal stromal cells through regulatory proteins and metabolic mechanisms, J. Immunol. Regen. Med, vol.1, pp.45-56, 2018.

P. Luz-crawford, Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells, Stem Cell Res. Ther, vol.4, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00836318

M. Kurte, IL17/IL17RA as a novel signaling axis driving mesenchymal stem cell therapeutic function in experimental autoimmune encephalomyelitis, Front. Immunol, vol.9, p.802, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01833410